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As sitosterolemic patients have an increased cardiovascular risk, there is concern that reducing serum
LDL-cholesterol concentrations by plant sterols enriched functional foods might adversely affect vas-
cular function. Whether increased concentrations of plant sterols truly affect vascular function and
whether these effects are exclusive to the larger vessels remains unknown. We compared the effects
of long-term plant sterol and -stanol consumption on changes in retinal vessels diameter which reﬂex
alterations in the microcirculation. Three randomized groups were studied at baseline and after 85-
weeks. Group one (N=11) consumed plant sterol enriched margarine (2.5 g/day), the second (N=8)
plant stanol enriched margarine (2.5 g/day), and the control group (N=11) non-enriched margarine
(2.5 g/day). Serum cholesterol-standardized campesterol and sitosterol concentrations increased by
354.84±168.22·102mol/mmol and84.36±48.26·102mol/mmol (p<0.001), respectively in the sterol
group, while decreasing non-signiﬁcantly in the plant stanol group. Serum LDL-cholesterol concentra-
tions decreased signiﬁcantly in both the plant sterol (−0.33±0.33mmol/L, p=0.016) and -stanol groups
(−0.38±0.34mmol/L, p=0.018) compared to the increase in the controls (0.29±0.34mmol/L). Themean
change in venular diameters for the plant sterol group (2.3±3.1m), plant stanol groups (−0.8±3.4m)
and control group (−0.8±5.1m) did not reach signiﬁcance but the change in cholesterol-standardized
campesterol concentrations correlated positively with the change in venular diameter independent of
changes in serumLDL-cholesterol concentrations (r=0.39,N=30,p=0.033). Increased serumcampesterol
posit
conc
functconcentration correlated
in serum LDL-cholesterol
plant sterols on vascular
. Introduction
Both plant sterol and -stanol esters are currently used as func-
ional food ingredients to reduce elevated serum LDL cholesterol
oncentrations. These effects have been shown in numerous pop-
lation groups – both in short- and long-term placebo controlled
ntervention studies [1]. As a result, these products have obtained
prominent position within guidelines to lower cardiovascular
isease risk [2]. However, some animal and human studies indi-
ate that slightly elevated serum plant sterol concentrations may
e atherogenic [3–6]. The basis behind this concern lies in ﬁnd-
ngs of premature coronary heart disease (CHD) in patients with
itosterolemia,which are characterized by severely elevated serum
lant sterol concentrations. Recently, several large cross-sectional
nd prospective cohort studies have therefore tried to link CHD
∗ Corresponding author at: University Eye Clinic Maastricht, PO Box 5800, NL-
202 AZ Maastricht, The Netherlands. Tel.: +31 43 387 2232; fax: +31 84 736 8491.
E-mail address: Elton.kelly@ohk.unimaas.nl (E.R. Kelly).
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Open access under the Elsevier OA license.ively with increased retinal venular diameter, independent from changes
entrations. This may constitute an explanation for the suggested effects of
ion. However, this novel ﬁnding needs conﬁrmation and further study.
© 2010 Elsevier Ireland Ltd. 
mortality rates to serum plant sterol concentrations and smaller
retinal arteriolar diameter. While some studies showed a positive
relationship between serum plant sterol concentrations and CHD
risk [7–9], others did not [10–12]. Altogether these ﬁndings are
as yet too inconsistent to draw any deﬁnitive conclusions in this
respect. Moreover, very recently after many years of debate and
careful weighing scientiﬁc data the Canadian authorities decided
to allow plant sterol enriched products on the Canadian market.
This suggests that the expected health improvements might out-
weigh the suggested atherogenicity. We here propose that this
potential atherogenicity might originate from effects on the micro-
circulation. Although cardiovascular disease is largely considered
a disease of the large vessels, evidence is accumulating that dis-
turbances in the microcirculation predict CHD risk [13]. Several
studies have indeed shown that a larger retinal venular diame-
Open access under the Elsevier OA license.ter associateswith establishedmarkers for atherosclerosis [14–16].
For example, in the Rotterdam Study subjects with larger venular
diameters had lower serumHDL cholesterol concentrations, higher
serum total cholesterol concentrations, a lower ankle–arm index,
a higher carotid-plaque score, and more aortic calciﬁcations [14].
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n addition, Wong et al. have shown that certain retinal microvas-
ular characteristics predict the incidence of stroke [17]. Finally,
ubbard et al. showed that a decreased arteriovenous ratio (AVR)
f 0.02 units predicts a 10mmHg increase in mean arterial blood
ressure (MABP) [18]. The relation between retinal microvascular
bnormalities andhypertensionwas later conﬁrmedbyWonget al.,
lthough they found no relation with atherosclerosis in their study
19].
To the best of our knowledge, there have been no studies eval-
ating or even monitoring the association between serum plant
terol concentrations, nor the effects of plant sterol or -stanol con-
umption on microvascular characteristics. Plant stanols are the
ydrogenated forms of plant sterols. These not only lower serum
DL-cholesterol concentrations, but also that of the serum plant
terols [20–22]. Therefore, in the present study we examined the
ssociation between changes in serum plant sterol concentrations
nd changes in retinal vessel diameter during an 85-week follow-
p study in which plant sterol or -stanol esters were consumed.
ll subjects were already on stable statin treatment for several
ears and consumed margarines enriched with either plant sterol
sters (2.5 g/day), -stanol esters (2.5 g/day), or not enriched at all
control). We have reported earlier that plant sterol or -stanol
ster consumption lowered serum LDL cholesterol concentrations
n this population over the intervention period of 85 weeks by
pproximately 10% [23].Wenowdescribe the effects of these inter-
entions on changes in the retinal vasculature diameter in relation
o changes in serum LDL cholesterol and cholesterol-standardized
lant sterol concentrations. These are secondary outcomes from a
arger study.
. Materials and methods
.1. Subjects
Subjects were recruited through local newspaper advertise-
ents and posters in the University and hospital buildings.
nclusion criteria were: current treatment with a 3-hydroxy-3-
ethylglutaryl-coenzyme A reductase inhibitor (statin), age 18–65
ears, body mass index (BMI)≤32kg/m2, no proteinuria or glu-
osuria, diastolic blood pressure≤95mmHg and systolic blood
ressure≤200mmHg. Since one of the purposes of this study was
o analyze the long-termeffects of plant sterol or -stanol esters con-
umption on serum lipoprotein metabolism [24], and on markers
f endothelial dysfunction and arterial stiffness in patients being
reated stably with statin (to be published elsewhere), statin use
as an inclusion criterion. Exclusion criteriawere antihypertensive
edication use, clinical manifestations of liver disorders, existing
iabetesmellitus type2ordemonstrationof cardiovascular or cere-
ral events within a period of 6 months prior to the study.
.2. Ethics
The protocol was approved by the Medical Ethical Committee of
he Maastricht University, and was conducted in accordance with
he Helsinki Declaration. Informed consent was gained from all
ubjects.
.3. Diet and design
Subjects were asked to replace their regular margarine or but-
er with the experimental ‘light’ margarines (40% fat) supplied by
s. They were instructed to consume 30g/day of the margarine
ivided over at least two meals during the day. During the run-in
eriod of 5-weeks, all subjects used the control margarine with-
ut added plan-sterols or -stanols. At the end of the run-in period,
ubjects were randomly allocated to one of the three experimentalis 214 (2011) 225–230
groups, stratiﬁed for sex and age in this double blinded interven-
tion trial. For the following 85 weeks (2003–2004), the ﬁrst group
(N=11) continued with the control margarine, while the other two
groups used the same margarine, but now enriched with either
plant sterols (2.5 g plant sterols/day; N=11) or plant stanols (2.5 g
plant stanols/day;N=8). Plant sterols and -stanolswereprovidedas
fatty acid esters obtained by transesteriﬁcation of free plant sterols
with sunﬂower oil based fatty acids (Unilever, Vlaardingen, The
Netherlands) or of free plant stanols with rapeseed oil based fatty
acids (WalterRauNeusserÖlundFettAG,Neuss,Germany) [24]. The
volunteers came to the university at least once a month to receive
their products. A diary was kept by the subjects to record any signs
of illness, change in medication, and amount of daily consumed
margarine. For the entire study-duration subjects were asked to
keep their normal diet, physical exercise level, and smoking and
alcohol consumption habits. Details of this study have already been
published [23].
2.4. Measurements
2.4.1. Serum lipids, plant sterols and plant stanols
Serum lipids and lipoproteins as well as serum plant sterol and
-stanol concentrations at the beginning and the end of the experi-
mental period were analyzed as described [23].
2.5. Fundus photography
Retinal imageswere taken at baseline (week 5) and at the end of
the experimental period (week 90). Mydriasis was achieved using
0.5% tropicamide and 2.5% phenylephrine. The fundus images were
taken using an analogue camera and were later digitized. Image-
editing software was used to remove the red (containing mostly
choroid information) and blue channels (containing no real useful
information) from the images leaving only the green light channel.
Removal of these two color-channels increases the contrast of the
retinal vessels in the remaining image [25,26].
Retinal images were registered using the Generalized Dual-
Bootstrap Iterative Closest Point (GDB-ICP) software developed
by Stewart and coworkers from the Rensselaer Polytechnic Insti-
tute (NY, USA). This registration process has been explained in
detail elsewhere [27]. In short, the registration automatically ini-
tializes and individually matches vascular landmarks. The images
are aligned based on detected vessel key-points using a quadratic
transformation with sub-pixel accuracy. The registration enabled
us to compare baseline with endpoint images accurately.
The registration was validated using the Retinal Analysis Opti-
mate System developed by Hubbard and colleagues from the
University of Wisconsin (WI, USA) and was considered to be valid if
the AV-ratio of the original image and the AV-ratio of the registered
image did not differ signiﬁcantly, thus suggesting that no distor-
tion took place during the registration process [14,18]. Note that
in the cross-sectional studies published so far, registration was not
required since in these types of studies, no comparisons of images
within subjects were made for different time points.
Measurements of the retinal vessel diameter were performed
using the same Retinal Analysis Optimate System as mentioned
before. For the retinal vessels diameter, themean of the four largest
arteries or the four largest veins was taken. The vessels type clas-
siﬁcation made by the program was conﬁrmed by an independent
ophthalmologist.2.6. Statistical analysis
Statistical analysis was performed using SPSS 17.0 for windows.
Differences in gender distribution over the experimental groups
were tested using the Pearson Chi-square test, while differences in
sclerosis 214 (2011) 225–230 227
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Table 2
Baseline concentrations and mean changes for serum lipids and lipoproteins, lath-
osterol, plant sterols and -stanols.
Group Baseline Follow up Change % Change
Total cholesterol
Sterol 5.19±0.88 4.95±0.72 −0.24±0.39 −3.9
Stanol 5.68±0.54 5.36±0.46 −0.32±0.41 −5.4
Control 5.16±0.88 5.45±0.86 0.29±0.34 5.9
p-Value 0.335 0.25 0.002
LDL cholesterol
Sterol 3.22±0.68 2.90±0.61 −0.32±0.33 −9.2
Stanol 3.42±0.48 3.09±0.49 −0.34±0.34 −9.6
Control 3.19±0.77 3.33±0.68 0.13±0.35 5.3
p-Value 0.733 0.292 0.006
HDL cholesterol
Sterol 1.28±0.34 1.42±0.32 0.14±0.10 12.4
Stanol 1.29±0.18 1.46±0.32 0.17±0.29 13.5
Control 1.32±0.20 1.35±0.21 0.03±0.17 2.9
p-Value 0.929 0.681 0.219
Lathosterol
Sterol 56.54±24.11 71.96±33.34 15.42±13.55 27.3
Stanol 58.02±18.54 65.04±21.76 7.02±20.67 12.1
Control 67.72±23.72 60.19±19.60 −7.53±6.30 −11.1
p-Value 0.474 0.574 0.002
Campesterol
Sterol 368±181 773±284 405±172 110
Stanol 196±97 168±64 −28±99 −14.3
Control 248±122 238±114 −9.63±32 −3.9
p-Value 0.035 <0.001 <0.001
Sitosterol
Sterol 233±111 336±120 103±41 44.2
Stanol 133±65 123±50 −9.03±46 −6.8
Control 170±69 174±77 3.79±33 2.2
p-Value 0.049 <0.0001 <0.0001
Campestanol
Sterol 4.06±1.33 9.22±1.95 5.16±1.44 127
Stanol 3.11±1.05 43.8±32 40.7±31 1309
Control 3.29±0.74 7.97±1.66 4.68±1.01 142
p-Value 0.126 <0.0001 <0.0001
Sitostanol
Sterol 3.33±1.16 2.78±0.64 −0.55±0.69 −16.5
Stanol 2.74±1.54 20.1±17 17.4±16 635
Control 2.94±0.80 2.93±0.80 −0.01±0.73 −0.3
p-Value 0.536 <0.0001 <0.0001
Analysis of variance: serum cholesterol concentrations are presented as
means± SD mmol/L. LDL and HDL cholesterol are means± SD for cholesterol-
standardized mmol/L. Plant sterol and -stanol values are cholesterol-standardized
T
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ge and lipids were evaluated using the ANOVA. The Students’ T-
est was used to evaluate the difference in serum LDL cholesterol
oncentrations between subjectswith (N=30) andwithout (N=17)
etinal images taken. AnANCOVAwith follow-up as dependent and
aseline levels and changes in sterols and stanols as independent
ariables was used to evaluate the relation between retinal ves-
el characteristics and serum sterol concentration. p-Values were
onsidered signiﬁcant if p<0.05. For post hoc test we applied the
onferroni correction. Results are shown as mean± standard devi-
tion (SD).
. Results
.1. Baseline characteristics
For this study 54 subjects, who met all the inclusion criteria,
ere recruited. These subjects were randomized into the three
roups. Because the number of subjects that we could transport to
he testing facilities for fundus photography (located 200km from
ur university buildings) was limited, only 46 subjects were able to
articipate in the ﬁrst retina photograph session. Of these 46 sub-
ects, only 43 subjects completed the entire study of 85 weeks. In
ddition, one subject with a change in serum total cholesterol con-
entrations of almost ﬁve SD’s from themean valuewas considered
n outlier and as such excluded from further analysis. Two more
ubjects failed to attend the second photograph session after 85
eeks, while ﬁve subjects were excluded from the statistical anal-
sis because theywere requested by their physician to change their
osage of statins during the 85 weeks follow-up period. Finally,
etinal images for ﬁve subjects were also excluded because of poor
uality. Thus, data of 30 subjects could be used, of which eleven
36.7%) participated in the sterol group, eight (26.7%) in the stanol
roup and the remaining eleven in the control group. Table 1 shows
he baseline characteristics. There was no signiﬁcant difference in
ender distribution between the three groups (p=0.305), and no
igniﬁcant differences in age, body-mass-index or blood pressure
etween the three groups at baseline. Therewerenoadverse effects
eported.
.2. Baseline serum lipids, lipoproteins, plant sterols and plant
tanols
Serum concentrations for lipids and lipoproteins and the
holesterol-standardized plant sterol and -stanol concentrations
t the end of the run in period (week 4/5) are shown in Table 2.
here were no signiﬁcant differences in the statin type used
n the three groups (p=0.846, data not shown). There were no
igniﬁcant differences in serum total cholesterol concentrations
etween the three groups (p=0.335). Also for HDL cholesterol,
riacylglycerol and LDL concentrations there were no signiﬁcant
ifferences (p=0.929, 0.192 and 0.733, respectively). At base-
ine, serum-cholesterol-standardized-campesterol (p=0.035) and
sitosterol (p=0.049) concentrationsdiffered signiﬁcantly between
he sterol and stanol group but they did not differ from the
able 1
aseline characteristics of the subjects in the three groups.
Gender Age (years) BMI (kgm−
Male Female
Sterol 6 5 59±9 25.6±2.2
Stanol 3 5 63±6 26.1± 2.1
Control 8 3 60±7 25.6±2.5
p-Value 0.305 0.591 0.863 0.594
alues are means± standard deviation.(means± SD×102 mol/mmol cholesterol).
control group. No signiﬁcant differences were observed between
serum-cholesterol-standardized-campestanol and sitostanol con-
centrations at baseline.
A comparison was made between the 30 subjects used in the
retinal analysis and those not participating (N=17) to ensure that
they had similar cholesterol concentrations at baseline and showed
no signiﬁcant difference for the control, sterol and stanol group
(p=0.963, 0.324, and 0.917, respectively). This suggests that the
30 subjects who were ﬁnally included in the analysis were a valid
representation of the entire group.
2) Blood pressure (mmHg) Hypertensive
S>140 or D>90mmHg
Systolic Diastolic
141.5±19.0 87.0±11.1 7
135.9±13.6 82.5±8.0 7
144.3±18.7 87.4±10.3 4
0.538 0.797
2 sclerosis 214 (2011) 225–230
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Table 4
Multiple linear regression analysis.
Model Variables Regression coefﬁcient
Dependent Independent B SE (ˇ) p-Value
Aa Mean follow-up
venular diameter
Mean baseline
venular diameter
0.98 0.55 <0.001
 cholesterol-
standardized
campesterol
concentration
0.0066 0.0032 0.049
Intercept 1.93
Bb Follow-up venular
diameter
(clustered)
Mean baseline
venular diameter
0.98 0.018 <0.001
 chol stand
Campesterol conc
0.0062 0.0027 0.032
Intercept 1.15
Total cholesterol, LDL cholesterol, and triglycerides did not contribute signiﬁcantly
in the initial model, and therefore they were not included in the ﬁnal model.
a Mean venular-diameter per subject as dependent variable.
b All veins included, clustered by subjects (i.e. four per subjects).
T
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.3. Effect of dietary plant sterols and stanols on serum LDL
holesterol concentrations
The plant sterol group had a 0.33mmol/L (9.7%; p=0.021)
reater decrease in serum LDL cholesterol concentration compared
o the control group over the entire 85 week intervention. In the
lant stanol group serum LDL cholesterol concentrations were
educed by 0.38mmol/L (11.2%; p=0.008). Measurements of lath-
sterol concentrations revealed a signiﬁcant increase between the
terol group and the control group (p=0.002 in a post hoc analysis).
.4. Effect on serum cholesterol-standardized plant sterol and
stanol concentrations
In the plant sterol group, cholesterol-standardized campesterol
p<0.001) and sitosterol (p<0.001) concentrations increased sig-
iﬁcantly as compared to the control and the plant stanol group,
hile no signiﬁcant effect on serum campestanol and sitostanol
oncentrations was seen. The plant stanol group had a signiﬁcant
ower baseline value for campesterol and sitosterol as compared
o the plant sterol group (p<0.05). A reduction in the cholesterol-
tandardized campesterol and sitosterol concentrations in the
lant stanol group as compared to the control group did not
each signiﬁcance. Plant stanol consumption increased the serum
holesterol-standardized campestanol and sitostanol concentra-
ions signiﬁcantly (p<0.001 in a post hoc analysis) as compared
o both the sterol and control groups (see Table 2).
.5. Retinal arteriolar and venular diameters
Table 3 shows the baseline values as well as the changes in the
iameter of the retinal arterioles and retinal venules during the
5-week study duration. Changes in the diameter of both the reti-
al arterioles and venules were not signiﬁcantly different between
he three dietary interventions (p=0.77 and p=0.15, respectively).
owever, for the retinal venular diameter, although not statisti-
ally signiﬁcant, there was an increase in mean diameter over time
n the plant sterol group as compared to the decrease observed in
he other two groups (Table 3).
Since there was a signiﬁcant difference in serum cholesterol-
tandardized plant sterol concentrations between the groups
t baseline, we also used ANCOVA with the follow-up venular
iameters as dependent variable and mean baseline venu-
ar diameters and changes in cholesterol-standardized serum-
lant sterol or -stanol concentrations as independent variables
Table 4). These results indicate a signiﬁcant contribution of
oth the baseline (ˇ =0.98, p<0.001) as well as the change
n cholesterol-standardized serum campesterol concentrations
ˇ =0.0066, p=0.049) on the follow-up venular diameters (model
). In this model we used the mean venular diameter per subject
s dependent variable. A more detailed ANCOVA analysis (model
), wherein all four veins of the individual subject were clus-
ered by subject (instead of the mean of the four venules used
efore) resulted in the sameoutcome for changes in serumcampes-
erol concentrations (ˇ =0.0062, p=0.032). Adding lathosterol to
able 3
aseline values and mean changes in retinal vessel diameter for the 3 groups.
Arteriole Venule
Baseline Diff Baseline
Sterols 91±18.5 −0.7±4.7 106±15
Stanols 89±8.4 0.6±3.1 109±14
Controls 89±8.3 −0.2±3.4 111±13
p-Value 0.931 0.766 0.705
alues are shown as m means± standard deviation.Fig. 1. Scatter plot showing association between change in serum campesterol con-
centration and change in venular diameter with regression line (r=0.39, p=0.033).
the statistical models did not reveal a signiﬁcant contribution of
changes in lathosterol concentrations to the observed increase in
venular diameter. To examine the potential relationship between
changes in serum cholesterol-standardized plant sterol concen-
trations and venular diameter in more detail, we searched for
associations between changes in venular diameter and changes in
serum lipid, lipoprotein and cholesterol-standardized plant sterol
or stanol concentrations (Fig. 1). We found that an increase in
serumplant sterol concentrationswas associatedwith a signiﬁcant
increase in venular diameter (r=0.387, p=0.034). Further anal-
ysis showed that this signiﬁcant correlation could be attributed
primarily to the change in serumcholesterol-standardized campes-
terol concentrations (r=0.39, p=0.033) in the sterol group. For
AV-ratio
Diff Baseline Diff
2.3±3.1 0.86±0.13 −0.03±0.05
−0.8±3.4 0.83±0.08 0.01±0.03
−0.8±5.1 0.81±0.11 0.00±0.04
0.149 0.574 0.077
E.R. Kelly et al. / Atheroscleros
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eig. 2. Scatter plot showing association between change in serum sitosterol con-
entration and change in venular diameter with regression line (r=0.35, p=0.056).
holesterol-standardized sitosterol concentrations this correlation
early reached statistical signiﬁcance (r=0.35, p=0.056, Fig. 2).
herewas no correlation betweenAV-ratio and serum campesterol
nd sitosterol changes (p>0.661).
As expected, the change in serum cholesterol-standardized
lant sterol concentrations (both sitosterol as well as campes-
erol) showed a signiﬁcant correlation with the change in serum
holesterol concentrations. However, the changes in retinal vein
iameters showed only a relation with changes in cholesterol-
tandardized serum campesterol concentrations but not with
hanges in serum cholesterol concentrations. There were also no
elationsbetweenchanges in serumcholesterol-standardizedplant
tanol concentrationsandretinal veindiameters. This indicates that
he observed changes in retinal veins are more closely related to
he increased plant sterol concentration and not to the decrease in
erum-LDL-cholesterol concentrations.
. Discussion
To the best of our knowledge we present here, for the ﬁrst time,
he effect of increased plant sterol- and stanol-enriched functional
ood consumption over time on the retinal vasculature. Previous
tudies have shown an association between retinal vasculature
hanges and markers for atherosclerosis or future CHD risk [14,28].
recent study by Kreis et al. failed however to show any signiﬁ-
ance between retinal vascular caliber and the severity of coronary
rtery disease [29]. Unfortunately we do not have the statistical
trength to stratify for gender as McGeechan et al. showed that
specially women with wider retinal vein caliber had an increased
azard ratio for CHD [30]. In our study, the group that consumed
lant sterols showed an increase in venular diameter over time,
hich did not reach statistical signiﬁcance when compared to the
hanges in the other two groups. Linear regression analysis indi-
ated however that there was a positive association between an
ncrease in cholesterol-standardized serum campesterol concen-
rations and an increase in venular diameter. Theplant stanol group
ad a lower baseline sterol level, leading probably to a smaller
hange in these values. Interestingly, the effects on venular diame-
erwere independent from changes in serumcholesterol, LDL, HDL,
r triglyceride concentrations. This may also explain why we found
o effects on venular diameter in the plant stanol ester treated
roup, although serum total and LDL cholesterol concentrations
ere lowered by a comparable percentage as in the plant sterol
ster group. If true, it might be expected for example that sitos-is 214 (2011) 225–230 229
terolemic patients – who are characterized by normal serum LDL
cholesterol concentrations, severely elevated serum plant sterol
concentrations, and a pronounced increase in CHD risk – would
be characterized by a severely disturbed microvasculature system
[31]. This has however never been evaluated in this patient group.
Although suggestive, it remains to be investigated what the
functional consequences of the observed increase in venular diam-
eter in terms of changed cardiovascular risk are. In this respect,
Kawasaki et al. showed that subjects with metabolic syndrome
had a mean venular diameter, which was 4.69m larger than that
observed in healthy subjects [32]. Ikram et al. found that for every
point increase in carotid plaque-score therewas an0.4mincrease
of the venular diameter, while every SD decrease in ankle–arm
index resulted in an increase of 1.3mof the venular diameter [14].
They also showed that current smokers had on average a 10m
larger venular diameter than nonsmokers after adjusting for age
and gender. In the light of those ﬁndings, the increase in venular
diameter of 2.3m we observed in the plant sterol group as com-
pared to the decrease in both the control and plant stanol group
is at least worth exploring. In contrast to other studies, we did not
ﬁnd any correlation between retinal venular diameter and other
established CHD risk factors.
The correlation between the increase in venular diameter
and increase in cholesterol-standardized sitosterol concentrations
almost reached statistical signiﬁcance (p=0.056). A possible expla-
nation for the lower signiﬁcant association between venular diam-
eters and serumcholesterol-standardized sitosterol concentrations
as compared to campesterol concentrations might be found in
the height of serum concentrations, especially after consumption
of the sterol ester enriched products. In the group consuming
plant sterol ester enriched foods, the increase in cholesterol-
standardized serum campesterol concentrations was four times
larger than that of sitosterol (405±172×102mol/mmol and
102±41×102mol/mmol, respectively; see Table 2). The associa-
tion between changes in serum cholesterol-standardized sitosterol
concentrations and changes in venular diameter did not reach sig-
niﬁcance. However it might still be possible that the observed
changes in mean venular diameter in the plant sterol group we
observed can be attributed to an increase in plant sterols in general
and not only to campesterol.
It is generally accepted that plant stanol consumption lowers
serum plant sterol concentrations by 10–42% [20–22]. This effect is
attributed to theabilityofplant stanols to lowernotonly the intesti-
nal absorptionof cholesterol but also that of plant sterols. Therefore
consumptionof plant stanols lowers not only serumcholesterol but
also serum plant sterol concentrations. In line with previous stud-
ies we found a mean reduction of cholesterol-standardized serum
campesterol concentrations of 28±99×102mol/mmol (14.3%)
and9±47×102mol/mmol (6.8%) for sitosterol in theplant stanol
esters group. No reduction in venular diameter was observed.
However, it is possible that the reduction in serum cholesterol-
standardized plant sterol concentrations induced by plant stanol
consumption is too small to be protective or have any effect at all.
This however demands further study.
An intriguing ﬁnal question that remains is how to explain the
observed effects of elevated cholesterol-standardized campesterol
concentrations – and maybe also those of sitosterol – on the retinal
venular diameter. One possible explanation might relate to cur-
rently unknown regulatory effects of plant sterols or one of its
metabolites within the wall of the retinal venules, which is not
seen with plant stanols or cholesterol. We do know for example
that plant sterols may oxidize into various oxidation products [33].
The reason that plant stanols do not show this effect might relate
to the absence of formation of the responsible metabolites from
plant stanols, or otherwise to the lower serum concentrations of
plant stanols as compared to plant sterols. Nagaoka et al. showed
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hat statin treatment affects retinal blood ﬂow in both arterioles
nd venules [34]. In a later study they reported that effects of
imvastatin on retinal arterioles were dose-dependent and nitric
xide-mediated [35]. Although of interest, effects on the retinal
enular diameter we observed in our study are independent of
tatin use since all groups were on statin treatment for already two
ears prior to being recruited in this trial and remained during the
ntire study period.
To summarize, we have shown that an increase in cholesterol-
tandardized serum campesterol concentrations observed during
ong-term consumption of plant sterol ester enriched functional
oods correlateswith increase in retinal venulardiameter. The func-
ional consequences of the increase in retinal venular diameter
n terms of affecting health demands further study, although the
bserved increase of 2.3m is certainly relevant when placed in
erspective to associations found in for example metabolic syn-
rome subjects and smokers.
We concluded that the positive correlation between the
ncreases in serum campesterol concentrations and increases in
etinal venular diameter – which was independent from changes
n serum LDL cholesterol concentrations – may be an explanation
or the suggested adverse effects of plant sterols on vascular func-
ion. This is however a biomarker and more evidence is needed
hat plant sterol consumption indeed affects the functioning of our
micro)vascular system. We are aware that this is the ﬁrst time
his relation has been studied and therefore it certainly needs con-
rmation. Therefore, clearly further studies are warranted before
omplete safety of functional foods containing plant sterols can be
udged.
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